You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

counterregulation

Showing 1 - 25 of 39
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hypoglycemia, type1diabetes Trial in Cincinnati (Fasting, Feeding)

Recruiting
  • Hypoglycemia
  • type1diabetes
  • Fasting
  • Feeding
  • Cincinnati, Ohio
    University of Cincinnati
Aug 2, 2023

Diabetes, Hypoglycemia Trial in Baton Rouge (hyperinsulinemic-hypoglycemic clamp, 13C-MRS procedure/Acetate infusion)

Recruiting
  • Diabetes
  • Hypoglycemia
  • hyperinsulinemic-hypoglycemic clamp
  • 13C-MRS procedure/Acetate infusion
  • Baton Rouge, Louisiana
    Pennington Biomedical Research Center
Aug 29, 2022

Type 1 Diabetes Trial in Charlottesville (Basal insulin alone, Basal pramlintide and reduced basal insulin, CGM)

Terminated
  • Type 1 Diabetes Mellitus
  • Basal insulin alone
  • +5 more
  • Charlottesville, Virginia
    University of Virginia Center for Diabetes Technology
Mar 10, 2022

Hypoglycemia Unawareness, Type 1 Diabetes, Healthy Trial in Philadelphia (RT-CGM)

Active, not recruiting
  • Hypoglycemia Unawareness
  • +2 more
  • RT-CGM
  • Philadelphia, Pennsylvania
  • +2 more
May 16, 2022

Type1diabetes, Hypoglycemia, Hypoglycemia Unawareness Trial in Philadelphia (Phentolamine, Propranolol, Placebo)

Active, not recruiting
  • Type1diabetes
  • +3 more
  • Philadelphia, Pennsylvania
    University of Pennsylvania - Institute for Diabetes, Obesity and
Mar 3, 2022

Type1diabetes, Hypoglycemia Unawareness, Nocturnal Hypoglycemia Trial in Philadelphia (MiniMed 670G system)

Active, not recruiting
  • Type1diabetes
  • +4 more
  • MiniMed 670G system
  • Philadelphia, Pennsylvania
  • +2 more
Sep 10, 2021

Type 1 Diabetes Trial in Stanford, Charlottesville (AP System (DiAs or inControl) with USS Virginia, Sensor-Augmented Pump

Completed
Has Results
  • Type 1 Diabetes Mellitus
  • AP System (DiAs or inControl) with USS Virginia
  • Sensor-Augmented Pump Therapy (placebo)
  • Stanford, California
  • +1 more
Sep 11, 2022

Type 2 Diabetes Trial in Malmö (Sitagliptin, Placebo)

Completed
Has Results
  • Type 2 Diabetes
  • Malmö, Sweden
    Skane University Hospital Malmö
Oct 14, 2018

Diabetes Complications Trial in Baltimore (Epinephrine, Saline infusion)

Recruiting
  • Diabetes Complications
  • Baltimore, Maryland
    University of Maryland, Baltimore
Apr 8, 2022

Postural Orthostatic Tachycardia Syndrome (POTS), POTS, Orthostatic Intolerance Trial in Hawthorne (Pyridostigmine, Digoxin,

Completed
  • Postural Orthostatic Tachycardia Syndrome (POTS)
  • +2 more
  • Hawthorne, New York
    New York Medical College/Bradhurst building
Sep 27, 2022

Type 1 Diabetes, Hypoglycemia Trial in Toronto (ZT-01 low dose, ZT-01 high dose, Placebo)

Terminated
  • Type 1 Diabetes
  • Hypoglycemia
  • ZT-01 low dose
  • +2 more
  • Toronto, Ontario, Canada
    LMC Manna Research
May 12, 2022

Diabetes, Hypoglycemia, Autonomic Failure Trial in Bronx (drug, dietary supplement, behavioral)

Active, not recruiting
  • Diabetes Mellitus
  • +2 more
  • Bronx, New York
    Albert Einstein College of Medicine / General Clinical Research
Jan 12, 2021

Type II Diabetes Trial in Lahore (Eccentric Exercises Dose)

Recruiting
  • Type II Diabetes Mellitus
  • Eccentric Exercises Dose
  • Lahore, Punjab, Pakistan
    Ghurki Trust Teaching Hospital
Aug 10, 2022

Diabetes, Diabetes, Type 2 Trial in Graz (semaglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Graz, Austria
    Novo Nordisk Investigational Site
Aug 9, 2018

Hypoglycemia Unawareness Trial in Salt Lake City (Carvedilol 3.125 mg, Carvedilol 2.5 mg, Placebo capsule)

Terminated
Has Results
  • Hypoglycemia Unawareness
  • Carvedilol 3.125 mg
  • +2 more
  • Salt Lake City, Utah
    University of Utah
Nov 10, 2020

Hypoglycemic Risk in Type 1 Diabetes

Not yet recruiting
  • Type 1 Diabetes
  • Hypoglycemia
  • Mixed Meal Tolerance Test (MMTT)
  • +2 more
  • Exeter, Devon, United Kingdom
    Royal Devon University Healthcare NHS Foundation Trust
Dec 19, 2022

Hypoglycemia With PET and a Norepinephrine Transporter Ligand

Completed
  • Hypoglycemia
  • Norepinephrine Transporter (NET) ligand
  • New Haven, Connecticut
    PET Center, YCCI Hospital Research Unit (HRU)
Mar 3, 2020

Type 1 Diabetes Trial in Salt Lake City (Propranolol 80 Mg Oral Capsule, Extended Release, Placebo oral capsule)

Terminated
Has Results
  • Type 1 Diabetes Mellitus
  • Propranolol 80 Mg Oral Capsule, Extended Release
  • Placebo oral capsule
  • Salt Lake City, Utah
    University of Utah
Aug 7, 2020

Diabetes, Type 2 Trial in Brampton, Etobicoke, Toronto (Basal insulin glargine and lixisenatide, Basal insulin Basaglar/Lantus +

Completed
  • Diabetes Mellitus, Type 2
  • Basal insulin glargine and lixisenatide
  • +2 more
  • Brampton, Ontario, Canada
  • +2 more
Feb 24, 2021

Type 1 Diabetes Trial in Charlottesville (Mixed meal and insulin challenge)

Completed
Has Results
  • Type 1 Diabetes Mellitus
  • Mixed meal and insulin challenge
  • Charlottesville, Virginia
    University of Virginia, Center for Diabetes Technology
Oct 24, 2016

Diabetes, Diabetes, Type 2 Trial in Bad Lauterberg (liraglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Bad Lauterberg, Germany
    Novo Nordisk Investigational Site
Jan 23, 2017

HIV-1 Infection Trial in Chapel Hill (Vorinostat, AGS-004)

Terminated
  • HIV-1 Infection
  • Chapel Hill, North Carolina
    University of North Carolina Hospitals
Oct 2, 2019

Obesity, Weight Loss, Weight Gain Trial in Berlin (multimodal lifestyle intervention, )

Completed
  • Obesity
  • +6 more
  • multimodal lifestyle intervention
  • placebo
  • Berlin, Germany
    Charite
Jan 12, 2018

Type 2 Diabetes Trial in Malmö (Lixisenatide)

Completed
  • Type 2 Diabetes
  • Malmö, Sweden
    Clinical Research Department
Dec 12, 2015

Diabetes, Type 1, Hypoglycemia Trial in Atlanta (Vigilant Diabetes Management Application)

Terminated
  • Diabetes Mellitus, Type 1
  • Hypoglycemia
  • Vigilant Diabetes Management Application
  • Atlanta, Georgia
    Atlanta Diabetes Associates
Feb 28, 2017